Vir Biotechnology Inc (VIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 172,299 | 299,322 | 361,722 | 312,332 | 257,948 |
| Marketable Securities | 336,429 | 394,915 | 528,091 | 682,401 | 746,124 |
| TOTAL | $545,684 | $735,706 | $932,207 | $1,042,458 | $1,047,157 |
| Non-Current Assets | |||||
| PPE Net | 58,203 | 60,795 | 61,681 | 63,183 | 64,791 |
| Investments And Advances | 304,212 | 286,099 | 218,140 | 190,015 | 271,495 |
| Intangibles | 24,861 | 24,935 | 25,009 | 25,057 | 36,196 |
| Other Non-Current Assets | 86,493 | 84,997 | 70,690 | 78,100 | 78,717 |
| TOTAL | $473,769 | $456,826 | $375,520 | $356,355 | $451,199 |
| Total Assets | $1,019,453 | $1,192,532 | $1,307,727 | $1,398,813 | $1,498,356 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,847 | 12,234 | 3,725 | 5,081 | 7,305 |
| Accrued Expenses | 68,375 | 82,661 | 104,126 | 85,873 | 94,658 |
| Other current liabilities | N/A | N/A | 17,500 | 16,060 | N/A |
| TOTAL | $75,222 | $105,004 | $137,286 | $119,662 | $117,161 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 10,109 | 11,935 | 12,648 | 15,198 |
| Other Non-Current Liabilities | 138,700 | 140,056 | 126,622 | 128,766 | 140,468 |
| TOTAL | $148,133 | $140,056 | $126,622 | $128,766 | $140,468 |
| Total Liabilities | $223,355 | $245,060 | $263,908 | $248,428 | $257,629 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 139,125 | 138,916 | 138,238 | 137,143 | 137,720 |
| Common Shares | 14 | 14 | 14 | 14 | 14 |
| Retained earnings | -1,154,848 | -991,707 | -880,749 | -759,784 | -655,195 |
| Other shareholders' equity | -1,911 | -2,221 | -1,975 | -1,717 | 1,127 |
| TOTAL | $796,098 | $947,472 | $1,043,819 | $1,150,385 | $1,240,727 |
| Total Liabilities And Equity | $1,019,453 | $1,192,532 | $1,307,727 | $1,398,813 | $1,498,356 |